The global vaginal pessary market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by factors such as increasing awareness about pelvic organ prolapse and incontinence, rising geriatric population, and increasing number of women suffering from these conditions.
Ring pessaries are expected to be the fastest-growing type segment in the global vaginal pessary market during the forecast period. This growth can be attributed to their ease of use and low cost compared with other types of vaginal pessaries. Shelf pessaries are expected to be the second-fastest growing type segment in this market during the forecast period due to their effectiveness in treating pelvic organ prolapse and incontinence symptoms without surgery or medication.
Some Of The Growth Factors Of This Market:
- Increasing number of women suffering from pelvic organ prolapse.
- Increasing awareness about the benefits of vaginal pessary.
- Growing preference for natural remedies over surgery.
- Rising incidence of gynecological disorders in developing countries.
- Increase in the number of women who are sexually active.
Industry Growth Insights published a new data on “Vaginal Pessary Market”. The research report is titled “Vaginal Pessary Market research by Types (Ring Pessary, Shelf Pessary), By Applications (Mild Pelvic Organ Prolapse, Stress Urinary Incontinence, Severe Pelvic Organ Prolapse), By Players/Companies CooperSurgical, MedGyn, Personal Medical Corp, Integra LifeSciences, Panpac Medical, Medesign, Smiths Medical, Thomas Medical, Kangge Medical, Dr. Arabin”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vaginal Pessary Market Research Report
By Type
Ring Pessary, Shelf Pessary
By Application
Mild Pelvic Organ Prolapse, Stress Urinary Incontinence, Severe Pelvic Organ Prolapse
By Companies
CooperSurgical, MedGyn, Personal Medical Corp, Integra LifeSciences, Panpac Medical, Medesign, Smiths Medical, Thomas Medical, Kangge Medical, Dr. Arabin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Vaginal Pessary Market Report Segments:
The global Vaginal Pessary market is segmented on the basis of:
Types
Ring Pessary, Shelf Pessary
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Mild Pelvic Organ Prolapse, Stress Urinary Incontinence, Severe Pelvic Organ Prolapse
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CooperSurgical
- MedGyn
- Personal Medical Corp
- Integra LifeSciences
- Panpac Medical
- Medesign
- Smiths Medical
- Thomas Medical
- Kangge Medical
- Dr. Arabin
Highlights of The Vaginal Pessary Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ring Pessary
- Shelf Pessary
- By Application:
- Mild Pelvic Organ Prolapse
- Stress Urinary Incontinence
- Severe Pelvic Organ Prolapse
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vaginal Pessary Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A vaginal pessary is a type of birth control device that is inserted into the vagina to prevent pregnancy. It is made of plastic, rubber, or metal and has a flexible neck that fits around the cervix. The pessary can be left in place for up to 12 hours at a time, and it can be removed by either the woman or her partner using gentle pressure.
Some of the major companies in the vaginal pessary market are CooperSurgical, MedGyn, Personal Medical Corp, Integra LifeSciences, Panpac Medical, Medesign, Smiths Medical, Thomas Medical, Kangge Medical, Dr. Arabin.
The vaginal pessary market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vaginal Pessary Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vaginal Pessary Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vaginal Pessary Market - Supply Chain
4.5. Global Vaginal Pessary Market Forecast
4.5.1. Vaginal Pessary Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vaginal Pessary Market Size (000 Units) and Y-o-Y Growth
4.5.3. Vaginal Pessary Market Absolute $ Opportunity
5. Global Vaginal Pessary Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Vaginal Pessary Market Size and Volume Forecast by Type
5.3.1. Ring Pessary
5.3.2. Shelf Pessary
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Vaginal Pessary Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Vaginal Pessary Market Size and Volume Forecast by Application
6.3.1. Mild Pelvic Organ Prolapse
6.3.2. Stress Urinary Incontinence
6.3.3. Severe Pelvic Organ Prolapse
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Vaginal Pessary Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Vaginal Pessary Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Vaginal Pessary Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Vaginal Pessary Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Vaginal Pessary Demand Share Forecast, 2019-2026
9. North America Vaginal Pessary Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Vaginal Pessary Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Vaginal Pessary Market Size and Volume Forecast by Application
9.4.1. Mild Pelvic Organ Prolapse
9.4.2. Stress Urinary Incontinence
9.4.3. Severe Pelvic Organ Prolapse
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Vaginal Pessary Market Size and Volume Forecast by Type
9.7.1. Ring Pessary
9.7.2. Shelf Pessary
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Vaginal Pessary Demand Share Forecast, 2019-2026
10. Latin America Vaginal Pessary Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Vaginal Pessary Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Vaginal Pessary Market Size and Volume Forecast by Application
10.4.1. Mild Pelvic Organ Prolapse
10.4.2. Stress Urinary Incontinence
10.4.3. Severe Pelvic Organ Prolapse
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Vaginal Pessary Market Size and Volume Forecast by Type
10.7.1. Ring Pessary
10.7.2. Shelf Pessary
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Vaginal Pessary Demand Share Forecast, 2019-2026
11. Europe Vaginal Pessary Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Vaginal Pessary Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Vaginal Pessary Market Size and Volume Forecast by Application
11.4.1. Mild Pelvic Organ Prolapse
11.4.2. Stress Urinary Incontinence
11.4.3. Severe Pelvic Organ Prolapse
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Vaginal Pessary Market Size and Volume Forecast by Type
11.7.1. Ring Pessary
11.7.2. Shelf Pessary
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Marke Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Vaginal Pessary Demand Share, 2019-2026
12. Asia Pacific Vaginal Pessary Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Vaginal Pessary Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Vaginal Pessary Market Size and Volume Forecast by Application
12.4.1. Mild Pelvic Organ Prolapse
12.4.2. Stress Urinary Incontinence
12.4.3. Severe Pelvic Organ Prolapse
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Vaginal Pessary Market Size and Volume Forecast by Type
12.7.1. Ring Pessary
12.7.2. Shelf Pessary
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Vaginal Pessary Demand Share, 2019-2026
13. Middle East & Africa Vaginal Pessary Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Vaginal Pessary Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Vaginal Pessary Market Size and Volume Forecast by Application
13.4.1. Mild Pelvic Organ Prolapse
13.4.2. Stress Urinary Incontinence
13.4.3. Severe Pelvic Organ Prolapse
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Vaginal Pessary Market Size and Volume Forecast by Type
13.7.1. Ring Pessary
13.7.2. Shelf Pessary
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Vaginal Pessary Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Vaginal Pessary Market: Market Share Analysis
14.2. Vaginal Pessary Distributors and Customers
14.3. Vaginal Pessary Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. CooperSurgical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. MedGyn
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Personal Medical Corp
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Integra LifeSciences
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Panpac Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Medesign
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Smiths Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Thomas Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Kangge Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Dr. Arabin
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
